Melanoma-cell toxicity of cystemustine combine with O6-benzyi- N2-acetylguanosine

Melanoma Research

Volumn 8, Issue 2, 1998, Pages 123-130

  Buchdahl, C ^a   Rolhion, C ^a   Glasser, A L ^a   Debiton, E ^a   Mounetou, E ^a   Madelmont, J C ^a   Laval, F ^a  

^a INSERM   (France)

Author keywords

Cystemustine; Inhibition of O6 methylguanine DNA methyltransferase; Melanoma treatment; O6 benzyl N2 acetylguanosine

Indexed keywords

6 O BENZYLGUANINE; CYSTEMUSTINE; GUANOSINE DERIVATIVE; O(6) BENZYL N(2) ACETYLGUANOSINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOTOXICITY; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; TUMOR REGRESSION;

EID: 0031898494     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199804000-00004     Document Type: Article

References (39)

1. Lee SM, Betticher DC, Thatcher N. Melanoma: chemotherapy. Br Med Bull 1995; 51: 609-630.
2. Madelmont JC. Cystemustine. Drugs Future 1994; 19: 27-30.
3. Godènche D, Labarre P, Cussac C, Madelmont JC, Dupuy M, Fontanon C, Tisserant A, Chollet P, Baudry JP, Veyre A. Pharmacokinetic of two new 2-chloroethyl-nitrosoureas in cancer patients submitted to phase II clinical trials. Drug Invest 1994; 7: 234-243.
4. 2 in advanced malignant melanoma. 19th ESMO Congress, Lisbon, 1994.
5. Tong WP, Kohn KW, Ludlum DB. Modifications of DNA by different haloethylnitrosoureas. Cancer Res 1982; 42: 4460-4464.
6. 6-methylguanine-DNA methyltransferase. J Biol Chem 1994; 269: 730-733.
7. Olsson M, Lindahl T. Repair of alkylated DNA in E. coli. J Biol Chem 1980; 255: 10568-10571.
8. 6-methylguanine-DNA methyltransferase activity induced by various treatments in mammalian cells. Cancer Res 1986; 46: 5701-5705.
9. 6-methylguanine-DNA methyltransferase and N3-methyladenine-DNA glycosylase in human cells. DNA Cell Biol 1993; 12: 233-241.
10. Habraken Y, Laval F. Enhancement of 1,3-bis(2-chloroethyl)-1-nitrosourea resistance by γ-irradiation or drug pretreatment in rat hepatoma cells. Cancer Res 1991; 51: 1217-1220.
11. 6-alkylguanine-DNA alkyltransferase (AT) in cancer chemotherapy. Cancer Treat Rev 1988; 15: 279-292.
12. 6-methylguanine-DNA methyltransferase activities in biopsies of human melanoma tumours. Br J Cancer 1995; 71: 37-39.
13. 6-alkylguanine-DNA alkyltransferase activity in human malignant melanoma. J Dermatol Sci 1992; 4: 6-10.
14. 6-methylguanine-DNA methyltransferase in human melanoma metastases. Eur J Cancer 1996; 33: 129-131.
15. Godenèche D, Rapp M, Thierry A, Laval F, Madelmont JC, Chollet P, Veyre A. DNA damage induced by a new 2-chloroethylnitrosourea on malignant melanoma. Cancer Res 1990; 50: 5898-5903.
16. 6-benzylguanosine. J Lab Comp 1992; XXXI: 793-800.
17. 6-benzyl-N-acetylguanosine derivatives of chloroethylnitrosourea antitumor action in chloroethylnitrosourea-resistant human malignant melanocytes. J Pharmacol Exp Ther 1994; 271: 1353-1358.
18. 6-alkylguanine-DNA alkyltransferase inhibitor in nude mice bearing human melanoma. Drug Metab Disposition 1994; 22: 637-642.
19. 2-acetylguanosine of N′-2-chloroethyl)N′-nitrosourea therapeutic index on nude mice bearing resistant human melanoma. Br J Cancer 1997; 76: 1157-1162.
20. 6-(alkyl/arakyl)guanosine and 2′-deoxyguanosine derivatives: synthesis and ability to enhance chloroethylnitrosourea antitumor action. J Med Chem 1997; 40: 2902-2909.
21. 6-benzylguanine. Biochemistry 1993; 32: 11998-12006.
22. Gibbs RA, Nguyen PN, Edwards A, Civitello AB, Casey CT. Multiples DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch Nyhan families. Genomics 1990; 7: 235-244.
23. Kalinowski DP, Illenye S, Van Houten B. Analysis of DNA damage and repair in murine leukemia L1210 cells using a quantitative polymerase chain resaction assay. Nucleic Acids Res 1992; 20: 3485-3494.
24. Cussac C, Laval E Reduction of the toxicity and the mutagenicity of aziridine in mammalian cells harboring the Escherichia coli fpg gene. Nucleic Acids Res 1996; 24: 1742-1746.
25. Jacubovich R, Cabrillat H, Gerbier D, Bailly M, Dorè JF. Tumorigenic phenotypes of human melanoma cell lines in nude mice determined by active antitumour mechanism. Br J Cancer 1985; 51: 335-345.
26. 6-methylguanine by mammalian cell extracts in alkylated DNA and poly(dG-m5dC)poly(dG-m5dC) in B and Z forms. Carcinogenesis 1985; 6: 805-807.
27. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory, 1989.
28. Phillips HJ. Dye exclusion tests for cell viability. In: Krusse PF, Patterson MK, eds. Tissue Culture Methods and Applications. 1973: 406-408.
29. 6-alkylguanine-DNA alkyltransferase. J Med Chem 1994; 37: 342-347.
30. 6-alkylguanine-DNA alkyltransferase. J Med Chem 1995; 38: 359-365.
31. 6-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitosourea. Biochemistry 1996; 35: 1328-1334.
32. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylation carcinogenic and therapeutic agents. Cancer Res 1990; 50: 6119-6129.
33. Jennerwein MM, Eastman A. Polymerase chain reaction-based method to detect cisplatin adducts in specific genes. Nucleic Acids Res 1991; 19: 6209-6214.
34. Gill RD, Cussac C, Souhami RL, Lavai F. Increased resistance to N,N′,N″-triethylenethiophosphoramide (thiotepa) in cells expressing the Escherichia coli formamidopyrimidine-DNA glycosylase. Cancer Res 1996; 56: 3721-3724.
35. Huberman E, Heckman, Langenbach R. Stimulation of differentiated functions in human melanoma cells by tumor promoting agents and dimethyl sulfoxide. Cancer Res 1979; 39: 2618-2624.
36. Tobey RA, Crissman HA. Comparative effects of three nitrosourea derivatives on mammalian cell cycle progression. Cancer Res 1975; 35: 460-470.
37. Vermes I, Haanen C. Apoptosis and programmed cell death in health and disease. Adv Clin Chem 1994; 31: 177-246.
38. Majno G, Joris I. Apoptosis, oncosis and necrosis. Am J Pathol 1995; 146: 3-15.
39. 6-alkylguanine-DNA alkyltransferase inhibitor. Biol Cell 1996; 88: 1-2.